Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 15 years, with Q2 2025 value amounting to $171000.0.

  • Lifecore Biomedical, Inc. \De\'s Non Operating Income rose 11551.72% to $171000.0 in Q2 2025 from the same period last year, while for May 2025 it was -$3000.0, marking a year-over-year increase of 9990.17%. This contributed to the annual value of -$3000.0 for FY2025, which is 9990.17% up from last year.
  • As of Q2 2025, Lifecore Biomedical, Inc. \De\'s Non Operating Income stood at $171000.0, which was up 11551.72% from $333000.0 recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Non Operating Income registered a high of $333000.0 during Q1 2025, and its lowest value of -$1.1 million during Q2 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Non Operating Income value was -$109500.0 (recorded in 2021), while the average stood at -$176444.4.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Non Operating Income skyrocketed by 34081.63% in 2022 and then tumbled by 88269.23% in 2024.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Non Operating Income stood at $330000.0 in 2021, then plummeted by 171.82% to -$237000.0 in 2022, then plummeted by 308.02% to -$967000.0 in 2023, then skyrocketed by 68.56% to -$304000.0 in 2024, then skyrocketed by 156.25% to $171000.0 in 2025.
  • Its last three reported values are $171000.0 in Q2 2025, $333000.0 for Q1 2025, and -$304000.0 during Q4 2024.